Fig. 3From: Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient populationInfluence of the median breast cancer CXCL13 content on distant disease-free survival in triple-negative cancer in the HE1097 trialBack to article page